WS #10130
US FDA advisers voted in favor of Moderna's flu vaccine, a key catalyst for MRNA and the biotech sector.
Moderna Flu Vaccine FDA Vote
US FDA advisers voted in favor of Moderna's flu vaccine, a key catalyst for MRNA and the biotech sector.
US FDA advisers voted in favor of Moderna's flu vaccine, a key catalyst for MRNA and the biotech sector.
US FDA advisers voted in favor of Moderna's flu vaccine, a key catalyst for MRNA and the biotech sector.